Results 301 to 310 of about 4,347,639 (355)

863 A multifaceted genetically engineered whole-cell vaccine platform generates potent, broad, persistent, and effector-centric anti-tumor immunity across multiple cancer indications

open access: gold
Miguel A. López-Lago   +10 more
openalex   +1 more source

Cysteine Peptidases in Antitumor Immunity: Unraveling Antigen‐Presenting Cell Regulation and Therapeutic Potential

open access: yesiMetaMed, EarlyView.
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including cathepsins B, S, L, and X, exert ...
Yimao Wu   +7 more
wiley   +1 more source

Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer. [PDF]

open access: yesSci Adv
Zhang Perkins F   +35 more
europepmc   +1 more source

Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects. [PDF]

open access: yesAdv Sci (Weinh)
Zhang J   +9 more
europepmc   +1 more source

Prospects and Challenges of Lung Cancer Vaccines. [PDF]

open access: yesVaccines (Basel)
Lin Z, Chen Z, Pei L, Chen Y, Ding Z.
europepmc   +1 more source

Cancer Vaccines

Current Protocols in Human Genetics, 1997
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
T F, Greten, E M, Jaffee
  +8 more sources

Home - About - Disclaimer - Privacy